The most recent study, showing the striking impact of complement genes on outcomes in renal cell carcinoma (RCC), found that C3aR-deficiency or blockade and C5aR1 blockade were all associated with reduced vascular density of tumors in a mouse model of RCC (117). Here, C3AR1 is linked to renal cell carcinoma.